David Sanford, Hagop Kantarjian, Jeffrey Skinner, Elias Jabbour, Jorge Cortes. Phase II trial of ponatinib in patients with chronic myeloid leukemia resistant to one previous tyrosine kinase inhibitor. Haematologica 2015;100(12):e494-e495; https://doi.org/10.3324/haematol.2015.132845.